Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes
Background The use of anti-CD20 monoclonal antibodies, such as rituximab and
ocrelizumab, has emerged as a matter of concern, in patients with coronavirus disease 2019 …
ocrelizumab, has emerged as a matter of concern, in patients with coronavirus disease 2019 …
Infectious Complications of Pulmonary Sarcoidosis
D Valeyre, JF Bernaudin, M Brauner, H Nunes… - Journal of Clinical …, 2024 - mdpi.com
In this review, the infectious complications observed in sarcoidosis are considered from a
practical point of view to help the clinician not to overlook them in a difficult context, as …
practical point of view to help the clinician not to overlook them in a difficult context, as …
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation …
HS Ørbo, KH Bjørlykke, J Sexton, I Jyssum… - RMD open, 2024 - rmdopen.bmj.com
Objectives To assess incidence, severity and predictors of COVID-19, including protective
post-vaccination levels of antibodies to the receptor-binding domain of SARS-CoV-2 spike …
post-vaccination levels of antibodies to the receptor-binding domain of SARS-CoV-2 spike …
[PDF][PDF] Hilde S Ørbo, Kristin H Bjørlykke, 2, 3 Joseph Sexton, Ingrid Jyssum, Anne T Tveter, Ingrid E Christensen, Siri Mjaaland, 4 Tore K Kvien, Gunnveig Grødeland, 2 …
Objectives To assess incidence, severity and predictors of COVID-19, including protective
postvaccination levels of antibodies to the receptor-binding domain of SARS-CoV-2 spike …
postvaccination levels of antibodies to the receptor-binding domain of SARS-CoV-2 spike …
[引用][C] The outcome of COVID‐19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?
ED Batu, A Erden - International journal of rheumatic diseases, 2023 - Wiley Online Library
Since the beginning of the COVID-19 pandemic, patients with autoimmune rheumatic
diseases (AIRDs) have been a focus of concern due to the underlying immune dysregulation …
diseases (AIRDs) have been a focus of concern due to the underlying immune dysregulation …